着床前遺伝子検査の世界市場レポート 2025年

着床前遺伝子検査の市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.2％で14億1,000万米ドルに成長します。予測期間の成長は、不妊治療クリニックの増加、遺伝カウンセリングサービスの成長、妊産婦の高年齢化、高度な遺伝学的検査プラットフォームの利用可能性の増加、PGT用途の拡大に起因しています。予測期間における主な動向には、高度なシーケンス技術の採用、拡張遺伝子パネルの導入、非侵襲的検査法の開発、胚培養システムの進歩、遺伝子編集技術の進歩などがあります。

体外受精（IVF）の施術数の増加が、今後の着床前遺伝子検査市場の拡大を牽引すると予測されます。体外受精は、体外で卵子と精子を受精させて胚を作り、それを子宮に移植します。体外受精の増加の背景には、生殖技術の進歩、不妊率の上昇、社会的認知の向上があります。このような体外受精の急増は、着床前の胚の遺伝子スクリーニングに対する需要の高まりにもつながっており、着床前遺伝子検査市場に利益をもたらしています。例えば、米国を拠点とする生殖補助医療協会（Society for Assisted Reproductive Technology）は2024年4月、2022年に体外受精によって9万1,771人の赤ちゃんが生まれたと報告しました。その結果、体外受精の増加が着床前遺伝子検査市場の成長に寄与しています。

着床前遺伝子検査市場の主要企業は、遺伝子スクリーニングの精度、効率、スピードを向上させるために次世代シーケンス（NGS）技術を進めています。NGSツールは、DNAおよびRNAの迅速かつハイスループットな解析を提供し、遺伝子変異および遺伝子発現に関する詳細な洞察を提供し、個別化医療を強化します。例えば、米国のバイオテクノロジー企業であるThermo Fisher Scientificは、2023年7月にIon ReproSeq PGT-A KitとIon AmpliSeq Polyploidy Kitを発表しました。これらのNGSツールは、Ion torrent genexus統合型シーケンサーを使用して、サンプル処理から異数性解析までのワークフローを合理化することにより、体外受精および顕微授精の研究を改善するように設計されています。この進歩により、胚スクリーニングが強化され、生殖補助医療技術の成功率が向上します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の着床前遺伝子検査市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の着床前遺伝子検査市場：成長率分析
• 世界の着床前遺伝子検査市場の実績：規模と成長、2019～2024年
• 世界の着床前遺伝子検査市場の予測：規模と成長、2024～2029年、2034年
• 世界の着床前遺伝子検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の着床前遺伝子検査市場：手順別、実績と予測、2019～2024年、2024～2029年、2034年
• 着床前遺伝子スクリーニング
• 着床前遺伝子診断
• 世界の着床前遺伝子検査市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
• 試薬および消耗品
• 機器
• ソフトウェア
• 世界の着床前遺伝子検査市場：技術別、実績と予測、2019～2024年、2024～2029年、2034年
• 次世代シーケンシング（NGS）
• ポリメラーゼ連鎖反応（PCR）
• 蛍光in situハイブリダイゼーション（FISH）
• その他
• 世界の着床前遺伝子検査市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 染色体異常
• 異数性スクリーニング
• X連鎖疾患
• 胚検査
• ヒト白血球抗原（HLA）型別
• その他
• 世界の着床前遺伝子検査市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• 不妊治療センター
• 診断センター
• 研究センターと学術研究室
• 世界の着床前遺伝子検査市場：着床前遺伝子スクリーニング（PGS）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アレイ比較ゲノムハイブリダイゼーション（aCGH）
• 次世代シーケンス（NGS）
• 蛍光in situハイブリダイゼーション（FISH）
• 世界の着床前遺伝子検査市場：着床前遺伝子診断（PGD）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 単一遺伝子疾患検査
• 染色体異常検査
• 幹細胞移植のためのHLAタイピング

第7章 地域別・国別分析

• 世界の着床前遺伝子検査市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の着床前遺伝子検査市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 着床前遺伝子検査市場：競合情勢
• 着床前遺伝子検査市場：企業プロファイル
  • 30.2.1.3概要、製品とサービス、戦略および財務分析
  • 30.2.2. By Procedure Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3.2概要、製品とサービス、戦略および財務分析
  • 30.2.4. Preimplantation Genetic Screening Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Preimplantation Genetic Diagnosis Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• By Application
• Chromosomal Abnormalities
• Aneuploidy Screening
• X-Linked Diseases
• Embryo Testing
• Human Leukocyte Antigen（HLA）Typing
• Other Applications
• By End User
• Hospitals
• Fertility Centers
• Diagnostic Centers
• Research Centers And Academic Labs
• Thermo Fisher Scientific

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 着床前遺伝子検査市場2029：新たな機会を提供する国
• 着床前遺伝子検査市場2029：新たな機会を提供するセグメント
• 着床前遺伝子検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Preimplantation genetic testing (PGT) is a procedure used to examine embryos for genetic abnormalities before they are implanted during in vitro fertilization (IVF). This testing aims to identify genetic issues to prevent certain inherited conditions, thus improving the chances of a successful pregnancy. PGT helps increase the likelihood of successful implantation, reduces the risk of miscarriage, and prevents genetic diseases.

The main types of preimplantation genetic testing are preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD). PGS involves analyzing embryos for chromosomal abnormalities before implantation. Products used in PGT include reagents and consumables, instruments, and software, and various technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), and fluorescent in situ hybridization (FISH). These procedures are employed for applications including chromosomal abnormalities, aneuploidy screening, X-linked diseases, embryo testing, and human leukocyte antigen (HLA) typing. The testing is utilized by various end users, including hospitals, fertility centers, diagnostic centers, research institutions, and academic laboratories.

The preimplantation genetic testing market research report is one of a series of new reports from The Business Research Company that provides preimplantation genetic testing market statistics, including preimplantation genetic testing industry global market size, regional shares, competitors with a preimplantation genetic testing market share, detailed preimplantation genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the preimplantation genetic testing industry. This preimplantation genetic testing market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The preimplantation genetic testing market size has grown rapidly in recent years. It will grow from $0.83 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing incidence of genetic disorders, growing awareness of genetic testing, increase in prenatal testing options, growing demand for personalized medicine, and increasing focus on preventive healthcare.

The preimplantation genetic testing market size is expected to see rapid growth in the next few years. It will grow to $1.41 billion in 2029 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to the rising number of fertility clinics, growth in genetic counseling services, growing prevalence of advanced maternal age, increasing availability of advanced genetic testing platforms, and expanding applications of PGT. Major trends in the forecast period include the adoption of advanced sequencing technologies, implementation of expanded genetic panels, development of non-invasive testing methods, advancements in embryo culture systems, and advancements in genetic editing technologies.

The growing number of in vitro fertilization (IVF) procedures is projected to drive the expansion of the preimplantation genetic testing market in the future. IVF involves fertilizing an egg with sperm outside the body to create an embryo, which is then implanted into the uterus. The increase in IVF procedures is fueled by advancements in reproductive technology, rising infertility rates, and greater public awareness. This surge in IVF practices is also leading to a higher demand for genetic screening of embryos before implantation, thereby benefiting the preimplantation genetic testing market. For example, the Society for Assisted Reproductive Technology, a U.S.-based organization, reported in April 2024 that 91,771 babies were born through IVF in 2022. Consequently, the rise in IVF procedures is contributing to the growth of the preimplantation genetic testing market.

Key players in the preimplantation genetic testing market are advancing next-generation sequencing (NGS) technologies to improve the accuracy, efficiency, and speed of genetic screening. NGS tools provide rapid, high-throughput analysis of DNA and RNA, offering detailed insights into genetic variations and gene expression, which enhances personalized medicine. For instance, in July 2023, Thermo Fisher Scientific, a US-based biotechnology firm, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These NGS tools are designed to improve IVF and ICSI research by streamlining workflows from sample processing to aneuploidy analysis using the ion torrent genexus integrated sequencer. This advancement enhances embryo screening and boosts success rates in assisted reproductive technologies.

In June 2022, Kindbody, a U.S.-based provider of fertility and wellness services, acquired the genomics company Phosphorus Labs for an undisclosed amount. This acquisition enables Kindbody to incorporate genetic testing capabilities into its fertility services, thereby improving patient care with personalized treatment plans. Phosphorus Labs specializes in preimplantation genetic testing in the U.S.

Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd, Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

North America was the largest region in the preimplantation genetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the preimplantation genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The preimplantation genetic testing (PGT) market consists of revenues earned by entities by providing services such as data analysis tools, genetic counseling, cloud-based platforms, and embryo selection algorithms. The market value includes the value of related goods sold by the service provider or included within the service offering. The preimplantation genetic testing (PGT) market also includes sales of genetic testing (PGT) kits, next-generation sequencers, and polymerase chain reaction (PCR) machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Preimplantation Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preimplantation genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for preimplantation genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preimplantation genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Procedure: Preimplantation Genetic Screening; Preimplantation Genetic Diagnosis
• 2) By Product: Reagents And Consumables; Instruments; Software
• 3) By Technology: Next Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescent In Situ Hybridization (FISH); Other Technologies
• 4) By Application: Chromosomal Abnormalities; Aneuploidy Screening; X-Linked Diseases; Embryo Testing; Human Leukocyte Antigen (HLA) Typing; Other Applications
• 5) By End User: Hospitals; Fertility Centers; Diagnostic Centers; Research Centers And Academic Labs
• Subsegments:
• 1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH); Next-Generation Sequencing (NGS); Fluorescence In Situ Hybridization (FISH)
• 2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing; Chromosomal Abnormalities Testing; HLA Typing for Stem Cell Transplantation
• Companies Mentioned: Thermo Fisher Scientific; Abbott Laboratories; Laboratory Corporation of America Holdings; Agilent Technologies Inc.; Illumina Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Preimplantation Genetic Testing Market Characteristics

3. Preimplantation Genetic Testing Market Trends And Strategies

4. Preimplantation Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Preimplantation Genetic Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Preimplantation Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Preimplantation Genetic Testing Market Growth Rate Analysis
• 5.4. Global Preimplantation Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Preimplantation Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Preimplantation Genetic Testing Total Addressable Market (TAM)

6. Preimplantation Genetic Testing Market Segmentation

• 6.1. Global Preimplantation Genetic Testing Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis
• 6.2. Global Preimplantation Genetic Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Reagents And Consumables
• Instruments
• Software
• 6.3. Global Preimplantation Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescent In Situ Hybridization (FISH)
• Other Technologies
• 6.4. Global Preimplantation Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chromosomal Abnormalities
• Aneuploidy Screening
• X-Linked Diseases
• Embryo Testing
• Human Leukocyte Antigen (HLA) Typing
• Other Applications
• 6.5. Global Preimplantation Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Fertility Centers
• Diagnostic Centers
• Research Centers And Academic Labs
• 6.6. Global Preimplantation Genetic Testing Market, Sub-Segmentation Of Preimplantation Genetic Screening (PGS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Array Comparative Genomic Hybridization (aCGH)
• Next-Generation Sequencing (NGS)
• Fluorescence In Situ Hybridization (FISH)
• 6.7. Global Preimplantation Genetic Testing Market, Sub-Segmentation Of Preimplantation Genetic Diagnosis (PGD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monogenic Disorders Testing
• Chromosomal Abnormalities Testing
• HLA Typing for Stem Cell Transplantation

7. Preimplantation Genetic Testing Market Regional And Country Analysis

• 7.1. Global Preimplantation Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Preimplantation Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Preimplantation Genetic Testing Market

• 8.1. Asia-Pacific Preimplantation Genetic Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

9. China Preimplantation Genetic Testing Market

• 9.1. China Preimplantation Genetic Testing Market Overview

10. India Preimplantation Genetic Testing Market

11. Japan Preimplantation Genetic Testing Market

• 11.1. Japan Preimplantation Genetic Testing Market Overview

12. Australia Preimplantation Genetic Testing Market

13. Indonesia Preimplantation Genetic Testing Market

14. South Korea Preimplantation Genetic Testing Market

• 14.1. South Korea Preimplantation Genetic Testing Market Overview

15. Western Europe Preimplantation Genetic Testing Market

• 15.1. Western Europe Preimplantation Genetic Testing Market Overview

16. UK Preimplantation Genetic Testing Market

17. Germany Preimplantation Genetic Testing Market

18. France Preimplantation Genetic Testing Market

19. Italy Preimplantation Genetic Testing Market

20. Spain Preimplantation Genetic Testing Market

21. Eastern Europe Preimplantation Genetic Testing Market

• 21.1. Eastern Europe Preimplantation Genetic Testing Market Overview

22. Russia Preimplantation Genetic Testing Market

23. North America Preimplantation Genetic Testing Market

• 23.1. North America Preimplantation Genetic Testing Market Overview

24. USA Preimplantation Genetic Testing Market

• 24.1. USA Preimplantation Genetic Testing Market Overview

25. Canada Preimplantation Genetic Testing Market

• 25.1. Canada Preimplantation Genetic Testing Market Overview

26. South America Preimplantation Genetic Testing Market

• 26.1. South America Preimplantation Genetic Testing Market Overview

27. Brazil Preimplantation Genetic Testing Market

28. Middle East Preimplantation Genetic Testing Market

• 28.1. Middle East Preimplantation Genetic Testing Market Overview

29. Africa Preimplantation Genetic Testing Market

• 29.1. Africa Preimplantation Genetic Testing Market Overview

30. Preimplantation Genetic Testing Market Competitive Landscape And Company Profiles

• 30.1. Preimplantation Genetic Testing Market Competitive Landscape
• 30.2. Preimplantation Genetic Testing Market Company Profiles
  • 30.2.1.3 Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. By Procedure Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3.2 Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Preimplantation Genetic Screening Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Preimplantation Genetic Diagnosis Overview, Products and Services, Strategy and Financial Analysis

31. Preimplantation Genetic Testing Market Other Major And Innovative Companies

• 31.1. By Application
• 31.2.6
• 31.3. Chromosomal Abnormalities
• 31.4. Aneuploidy Screening
• 31.5. X-Linked Diseases
• 31.6. Embryo Testing
• 31.7. Human Leukocyte Antigen (HLA) Typing
• 31.8. Other Applications
• 31.9. By End User
• 31.10.4
• 31.11. Hospitals
• 31.12. Fertility Centers
• 31.13. Diagnostic Centers
• 31.14. Research Centers And Academic Labs
• 31.15. Thermo Fisher Scientific

32. Global Preimplantation Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Preimplantation Genetic Testing Market

34. Recent Developments In The Preimplantation Genetic Testing Market

35. Preimplantation Genetic Testing Market High Potential Countries, Segments and Strategies

• 35.1 Preimplantation Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Preimplantation Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Preimplantation Genetic Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33526_Preimplantation_Genetic_Testing_GMR_2025